These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 30547811)

  • 21. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y
    Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation field size and dose determine oncologic outcome in esophageal cancer.
    Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
    World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
    Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
    Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic Submucosal Dissection for Superficial Proximal Esophageal Neoplasia is Highly Successful.
    Zhang YQ; Chen T; Zhang C; Li QL; Chen WF; Yao LQ; Zhou PH; Xu MD
    Ann Surg; 2017 Dec; 266(6):995-999. PubMed ID: 29140849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis.
    Min YW; Lee H; Song BG; Min BH; Kim HK; Choi YS; Lee JH; Hwang NY; Carriere KC; Rhee PL; Kim JJ; Zo JI; Shim YM
    Gastrointest Endosc; 2018 Oct; 88(4):624-633. PubMed ID: 29750981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical Esophageal Cancer Treatment Strategies: A Cohort Study Appraising the Debated Role of Surgery.
    Valmasoni M; Pierobon ES; Zanchettin G; Briscolini D; Moletta L; Ruol A; Salvador R; Merigliano S
    Ann Surg Oncol; 2018 Sep; 25(9):2747-2755. PubMed ID: 29987601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
    Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
    Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
    Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
    Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscular metastasis of superficial esophageal squamous cell carcinoma: a rare case of recurrence after endoscopic submucosal dissection with additional chemoradiotherapy.
    Saito H; Tanaka I; Akahira JI; Endo M; Igarashi K; Okuzono T; Nakahori M; Hirasawa D; Matsuda T
    Clin J Gastroenterol; 2023 Apr; 16(2):130-135. PubMed ID: 36370153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP
    Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of Surgical Resection of T1bN0 Esophageal Cancer and Assessment of Endoscopic Mucosal Resection for Identifying Low-Risk Cancers Appropriate for Endoscopic Therapy.
    Mohiuddin K; Dorer R; El Lakis MA; Hahn H; Speicher J; Hubka M; Low DE
    Ann Surg Oncol; 2016 Aug; 23(8):2673-8. PubMed ID: 27020584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcome of Additional Esophagectomy After Endoscopic Treatment for Superficial Esophageal Cancer.
    Miyata H; Sugimura K; Kanemura T; Takeoka T; Yamamoto M; Shinno N; Hara H; Omori T; Yamamoto S; Ishihara R; Wada H; Takahashi H; Nishimura J; Matsuda C; Yasui M; Yano M
    Ann Surg Oncol; 2021 Nov; 28(12):7230-7239. PubMed ID: 33959832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
    Erhunmwunsee L; Englum BR; Onaitis MW; D'Amico TA; Berry MF
    Ann Surg Oncol; 2015 Mar; 22(3):1020-5. PubMed ID: 25234017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic management of esophageal cancer after definitive chemoradiotherapy.
    Khangura SK; Greenwald BD
    Dig Dis Sci; 2013 Jun; 58(6):1477-85. PubMed ID: 23325163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Strategy after Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma: A Single Institution Experience.
    Lee HJ; Lee H; Park JC; Shin SK; Lee SK; Lee YC
    Gut Liver; 2015 Nov; 9(6):714-9. PubMed ID: 25473076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.